(3R)-3-AMINO-3-(2,3-DIFLUOROPHENYL)PROPANOIC ACID, 95%, 1g

Méthylimidazole, min.99%, pour la synthèse, 100 ml, emballage en verre

2-Methoxy-6-methylbenzoic acid, 98.0%, 1g

(5-Bromo-3-(trifluoromethyl)pyridin-2-yl)methanol, 95.0%, 25mg

(R)-TERT-BUTYL 3-(2-METHOXYETHOXY) PYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

Silver trifluoromethanesulfonate, 99.0%, 1g

4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95.0%, 250mg

(10-(Naphthalen-1-yl)anthracen-9-yl)boronic acid, 95.0%, 5g

(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol hydrochloride, 95.0%, 5g

Clemizole Hydrochloride>98.0%(HPLC)100mg

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97.0%, 25g

3-chloro-1,2,4-thiadiazol-5-amine, 98%, 5g

3-(4-methyl-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)-1??-thiolane-1,1-dione, 98%, 250mg